Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 32.82
-0.44 (-1.32%)
Sep 2, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.78 billion as of September 2, 2025. Its market cap has increased by 8.99% in one year.
Market Cap
2.78B
Enterprise Value
3.33B
Revenue
196.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.82
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.78B, an increase of 8,958.02%. That is a compound annual growth rate of 29.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 2.82B | 6.05% |
| Dec 30, 2024 | 2.66B | 93.47% |
| Dec 29, 2023 | 1.37B | -46.77% |
| Dec 30, 2022 | 2.58B | -34.64% |
| Dec 30, 2021 | 3.95B | -63.06% |
| Dec 30, 2020 | 10.69B | 218.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 99.39B |
| Sectra AB | 63.89B |
| Getinge AB | 56.43B |
| Camurus AB | 42.78B |
| Medicover AB | 39.93B |
| Asker Healthcare Group AB | 36.74B |
| BioArctic AB | 26.79B |
| AddLife AB | 21.57B |